Fellow shareholders, finally we are in the new year 2017!
I am looking forward to IPD to deliver on most of the drivers below!
2017 - Expansion Drivers• Introduction of SOZOTM expected to drive acceleration of sales
• Reimbursement increase commencing 1 January 2017 (Potentially
pushes testing time from December 2016)
• Double customer base in top tier cancer centres
• Continue to add NCCN Alliance Cancer Centres
• Clinical and Study data generated globally to drive uptake
• Private payors begin to cover
• Expand to all cancer related lymphoedema in original CY2016 highvalue
cancer centres
• Commence at-home business
• Apply to NCCN for inclusion of our technology (BIS) in cancer
guidelines
(testing takes seconds vs ~10 min)
Year 2017: The Game-Changing Year?
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $111.2M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.5¢ | $47.99K | 858.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 513413 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 102335 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IPD (ASX) Chart |